Aromatase inhibitor

Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma
Munekage Yamaguchi, Chimeddulam Erdenebaatar, Fumitaka Saito, Takeshi Motohara, Yo Miyahara, Hironori Tashiro, Hidetaka Katabuchi

International Journal of Gynecologic Cancer Nov 2015, 25 (9) 1645-1651; DOI: 10.1097/IGC.0000000000000557
Clinical Response to Antiestrogen Therapy in Platinum-Resistant Ovarian Cancer Patients and the Role of Tumor Estrogen Receptor Expression Status
Marina Stasenko, Melissa Plegue, Andrew P. Sciallis, Karen McLean

International Journal of Gynecologic Cancer Feb 2015, 25 (2) 222-228; DOI: 10.1097/IGC.0000000000000334
Treatment of aggressive angiomyxoma with aromatase inhibitor prior to surgical resection
D. L. Giles, P. T. Liu, T. K. Lidner, P. M. Magtibay

International Journal of Gynecologic Cancer Feb 2008, 18 (2) 375-379; DOI: 10.1111/j.1525-1438.2007.01005.x
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women
Huimei Zhou, Dongyan Cao, Jiaxin Yang, Keng Shen, Jinghe Lang

International Journal of Gynecologic Cancer Jul 2017, 27 (6) 1178-1182; DOI: 10.1097/IGC.0000000000001008
Promising Effect of Aromatase Inhibitors on Recurrent Granulosa Cell Tumors
Jacob Korach, Tamar Perri, Mario Beiner, Tima Davidzon, Eddie Fridman, Gilad Ben-Baruch

International Journal of Gynecologic Cancer Jul 2009, 19 (5) 830-833; DOI: 10.1111/IGC.0b013e3181a261d7

Log in using your username and password

Main menu

Log in using your username and password

You are here

Aromatase inhibitor